Drug profile · INN
trivalent influenza vaccine (recombinant, prepared in cell culture)
SUPEMTEK
trivalent influenza vaccine (recombinant, prepared in cell culture) (SUPEMTEK) is an FDA-listed pharmaceutical active ingredient.
EMA: approved Antiinfectives for systemic use (J07) J07BB02
Patents linked 0
Pipeline programs 4
News articles 0
Drug details — trivalent influenza vaccine (recombinant, prepared in cell culture)
- Class
- Antiinfectives for systemic use (J07)
- Route
- —
- Patents
- 0
- Programs
- 4
- Data quality
- 0.83
Quick answer
trivalent influenza vaccine (recombinant, prepared in cell culture) (SUPEMTEK) is an FDA-listed pharmaceutical active ingredient.
Key facts
INN trivalent influenza vaccine (recombinant, prepared in cell culture)
Brand SUPEMTEK
Therapeutic class Antiinfectives for systemic use (J07)
ATC code J07BB02
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is trivalent influenza vaccine (recombinant, prepared in cell culture)?
trivalent influenza vaccine (recombinant, prepared in cell culture) (SUPEMTEK) is an FDA-listed pharmaceutical active ingredient.
What is the brand name for trivalent influenza vaccine (recombinant, prepared in cell culture)?
SUPEMTEK is a marketed brand name for trivalent influenza vaccine (recombinant, prepared in cell culture). Check FDA Drugs@FDA for the current US label holder and prescribing information.